Description
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Product Unit Size | Cost | Quantity | Stock |
---|
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
Cas No. | 1874276-76-2 |
---|---|
Purity | ≥98% |
Formula | C22H23F3N8O |
Formula Wt. | 472.48 |
Chemical Name | LXS-196 |
IUPAC Name | 3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide |
Synonym | LXS 196, LXS196, NVP-LXS196, Darovasertib |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Thienylbutyl ITC analog.
Imidazole; 14-α demethylase, H+/K+ ATPase, Na+...
NO donor; AR antagonist.
Mycotoxin produced by species of Aspergillus; D...
Triterpene isolated Trypterigium wilfordii; HSP...
AMPK activator.
Quinolone, antioxidant.
STING antagonist
Semi-synthetic derivative of chlorophyll; food ...
Endogenous NMDA receptor antagonist.
Induces ER degradation.
Peptide, involved in neutrophil activation; FPR...
Endogenous proneurotensin peptide, involved in ...
Inhibitor of PI3K.
Flavone found in Teucrium.
Peptide hormone found in Solanaceae family plan...
Dihydrofolate reductase inhibitor.
Recombinant HIV-1 multi-epitope chimeric antige...
Natriuretic, vasodilatory peptide fragment; B1/...
VEGFR2, PDGFR, FGFR2 inhibitor.